Anti-Human APP Recombinant Antibody(Donanemab)
-
产品编号
YR1541
-
别名
科研级 Donanemab (多奈单抗 ), Anti-APP Recombinant Antibody, Research Grade Donanemab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Donanemab (多奈单抗 ), Anti-APP Recombinant Antibody, Research Grade Donanemab |
| Catalog Number | YR1541 |
| Molecular Name | Donanemab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Donanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer’s disease. Donanemab has shown positive results in Eli Lilly and Co.’s first two trials. |
| CAS Number | 1931944-80-7 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | APP[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
